From the Halifax Chronicle Herald:
Health Canada has given pharmaceutical giant GlaxoSmithKline permission to market its flu drug Relenza for the prevention of influenza, not merely the treatment of the illness.
The Canadian approval, announced by GSK on Thursday, follows in the footsteps of similar approvals by regulators in the United States and 15 European Union countries.
Other flu drugs on the market here — Tamiflu and the generic drug amantadine — were already approved for prevention of influenza. ...more
Links to the latest news in the world of pharmacy with a focus on items most relevant to Canadian pharmacists or others that are interested in Canadian pharmacies. This includes news about Canadian pharmacy seen in the mainstream media on topics such as new drug information and the international pharmacy industry.
Saturday, January 06, 2007
Flu drug Relenza gets approval from Health Canada
The headline sounds bigger than the actual news. Relenza now has the official indication for prevention of influenza.
No comments:
Post a Comment